Oncofetal reprogramming in tumour development and progression

A Sharma, C Blériot, J Currenti, F Ginhoux - Nature Reviews Cancer, 2022 - nature.com
Embryonic development is characterized by rapidly dividing cells, cellular plasticity and a
highly vascular microenvironment. These features are similar to those of tumour tissue, in …

GnRH and GnRH receptors in the pathophysiology of the human female reproductive system

R Maggi, AM Cariboni, MM Marelli… - Human reproduction …, 2016 - academic.oup.com
BACKGROUND Human reproduction depends on an intact hypothalamic–pituitary–gonadal
(HPG) axis. Hypothalamic gonadotrophin-releasing hormone (GnRH) has been recognized …

Prognostic biomarkers in endometrial cancer: a systematic review and meta-analysis

E Coll-de la Rubia, E Martinez-Garcia… - Journal of clinical …, 2020 - mdpi.com
Endometrial cancer (EC) is the sixth most common cancer in women worldwide and its
mortality is directly associated with the presence of poor prognostic factors driving tumor …

Current and emerging prognostic biomarkers in endometrial cancer

K Njoku, CE Barr, EJ Crosbie - Frontiers in Oncology, 2022 - frontiersin.org
Endometrial cancer is the most common gynaecological malignancy in high income
countries and its incidence is rising. Whilst most women with endometrial cancer are …

Cervical cancer markers: epigenetics and microRNAs

V Laengsri, U Kerdpin, C Plabplueng… - Laboratory …, 2018 - academic.oup.com
Gynecologic malignant neoplasms are a severe health problem among female patients, of
which cervical cancer (CC), in particular, is a common disease leading to high mortality …

Detecting endometrial cancer by blood spectroscopy: a diagnostic cross-sectional study

M Paraskevaidi, CLM Morais, KM Ashton… - Cancers, 2020 - mdpi.com
Endometrial cancer is the sixth most common cancer in women, with a rising incidence
worldwide. Current approaches for the diagnosis and screening of endometrial cancer are …

Discovery of biomarkers for endometrial cancer: current status and prospects

TL Rižner - Expert review of molecular diagnostics, 2016 - Taylor & Francis
Introduction: Endometrial cancer is the most frequent gynecological malignancy in the
developed world. Currently, endometrial histology is the gold standard for diagnosis, as …

[HTML][HTML] Correlation of CA-125 serum level and clinico-pathological characteristic of patients with endometriosis

M Karimi-Zarchi, N Dehshiri-Zadeh… - International journal …, 2016 - ncbi.nlm.nih.gov
Background: Cancer antigen 125 (CA-125) is a glycoprotein biomarker that is used in
women with pelvic masses such as endometriosis and maybe is useful in practice of patients …

The relationship between serum CA-125 level and recurrence in surgical stage I endometrial cancer patients

HH Wu, HT Chou, JY Tseng, IS Chan… - Journal of the Chinese …, 2023 - journals.lww.com
Background: The majority of patients diagnosed with early stage endometrial cancer have a
favorable prognosis; however, approximately 10% to 15% experience a recurrence …

CA 125 is a better marker to differentiate endometrial cancer and abnormal uterine bleeding

NU Kumar, MG Sridhar, K Srilatha, S Habebullah - African health sciences, 2018 - ajol.info
Background: Incidence of endometrial cancer in India is increasing due to lifestyle changes
and obesity. As 5 year survival rate of cancer confined to uterus is good, there is need for …